{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:48:15Z","timestamp":1787510895220,"version":"build-2736575974"},"reference-count":161,"publisher":"Bentham Science Publishers Ltd.","issue":"17","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health, NIH","doi-asserted-by":"publisher","award":["R01DC009606"],"award-info":[{"award-number":["R01DC009606"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,8,27]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Ciliopathies are a class of inherited pleiotropic genetic disorders in which alterations in cilia assembly, maintenance, and\/or function exhibit penetrance in the multiple organ systems. Olfactory dysfunction is one such clinical manifestation that has been shown in both patients and model organisms. Existing therapies for ciliopathies are limited to the treatment or management of symptoms. The last decade has seen an increase in potential curative therapeutic options including small molecules and biologics. Recent work in multiciliated olfactory sensory neurons has demonstrated the capacity of targeted gene therapy to restore ciliation in terminally differentiated cells and rescue olfactory function. This review will discuss the current understanding of the penetrance of ciliopathies in the olfactory system. Importantly, it will highlight both pharmacological and biological approaches, and their potential therapeutic value in the olfactory system and other ciliated tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We undertook a structured and comprehensive search of peer-reviewed research literature encompassing in vitro, in vivo, model organism, and clinical studies. From these publications, we describe the olfactory system, and discuss the penetrance of ciliopathies and impact of cilia loss on olfactory function. In addition, we outlined the developing therapies for ciliopathies across different organ and cell culture systems, and discussed their potential therapeutic application to the mammalian olfactory system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>One-hundred sixty-one manuscripts were included in the review, centering on the understanding of olfactory penetrance of ciliopathies, and discussing the potential therapeutic options for ciliopathies in the context of the mammalian olfactory system. Forty-four manuscripts were used to generate a table listing the known congenital causes of olfactory dysfunction, with the first ten listed are linked to ciliopathies. Twenty-three manuscripts were used to outline the potential of small molecules for the olfactory system. Emphasis was placed on HDAC6 inhibitors and lithium, both of which were shown to stabilize microtubule structures, contributing to ciliogenesis and cilia lengthening. Seventy-five manuscripts were used to describe gene therapy and gene therapeutic strategies. Included were the implementation of adenoviral, adeno-associated virus (AAV), and lentiviral vectors to treat ciliopathies across different organ systems and application toward the olfactory system. Thus far, adenoviral and AAVmeditated ciliary restoration demonstrated successful proof-of-principle preclinical studies. In addition, gene editing, ex vivo gene therapy, and transplantation could serve as alternative therapeutic and long-term approaches. But for all approaches, additional assessment of vector immunogenicity, specificity, and efficacy need further investigation. Currently, ciliopathy treatments are limited to symptomatic management with no curative options. However, the accessibility and amenability of the olfactory system to treatment would facilitate development and advancement of a viable therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The findings of this review highlight the contribution of ciliopathies to a growing list of congenial olfactory dysfunctions. Promising results from other organ systems imply the feasibility of biologics, with results from gene therapies proving to be a viable therapeutic option for ciliopathies and olfactory dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867325666180105102447","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T12:13:51Z","timestamp":1566908031000},"page":"3103-3119","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Olfactory Loss and Dysfunction in Ciliopathies: Molecular Mechanisms and Potential Therapies"],"prefix":"10.2174","volume":"26","author":[{"given":"Cedric R.","family":"Uytingco","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL 32610, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren W.","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL 32610, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Martens","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL 32610, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"R526","DOI":"10.1016\/j.cub.2009.05.025","volume":"19","author":"Berbari N.F.","year":"2009","unstructured":"Berbari N.F.; O\u2019Connor A.K.; Haycraft C.J.; Yoder B.K.; The primary cilium as a complex signaling center. Curr Biol 2009,19(13),R526-R535","journal-title":"Curr Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrg2774","volume":"11","author":"Goetz S.C.","year":"2010","unstructured":"Goetz S.C.; Anderson K.V.; The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet 2010,11(5),331-344","journal-title":"Nat Rev Genet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.diff.2011.11.002","volume":"83","author":"Takeda S.","year":"2012","unstructured":"Takeda S.; Narita K.; Structure and function of vertebrate cilia, towards a new taxonomy. Differentiation 2012,83(2),S4-S11","journal-title":"Differentiation"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1513\/pats.201103-025SD","volume":"8","author":"Ware S.M.","year":"2011","unstructured":"Ware S.M.; Aygun M.G.; -; Hildebrandt, F. Spectrum of clinical diseases caused by disorders of primary cilia. Proc Am Thorac Soc 2011,8(5),444-450","journal-title":"Proc Am Thorac Soc"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrm.2017.60","volume":"18","author":"Reiter J.F.","year":"2017","unstructured":"Reiter J.F.; Leroux M.R.; Genes and molecular pathways underpinning ciliopathies. Nat Rev Mol Cell Biol 2017,18(9),533-547","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1242\/jcs.78.1.283","volume":"78","author":"Menco B.P.","year":"1985","unstructured":"Menco B.P.; Farbman A.I.; Genesis of cilia and microvilli of rat nasal epithelia during pre-natal development. I. Olfactory epithelium, qualitative studies. J Cell Sci 1985,78,283-310","journal-title":"J Cell Sci"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1242\/jcs.78.1.311","volume":"78","author":"Menco B.P.","year":"1985","unstructured":"Menco B.P.; Farbman A.I.; Genesis of cilia and microvilli of rat nasal epithelia during pre-natal development. II. Olfactory epithelium, a morphometric analysis. J Cell Sci 1985,78,311-336","journal-title":"J Cell Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"13761","DOI":"10.1523\/JNEUROSCI.1708-15.2015","volume":"35","author":"Joiner A.M.","year":"2015","unstructured":"Joiner A.M.; Green W.W.; McIntyre J.C.; Allen B.L.; Schwob J.E.; Martens J.R.; Primary cilia on horizontal basal cells regulate regeneration of the olfactory epithelium. J Neurosci 2015,35(40),13761-13772","journal-title":"J Neurosci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1038\/ncomms6813","volume":"5","author":"Williams C.L.","year":"2014","unstructured":"Williams C.L.; McIntyre J.C.; Norris S.R.; Jenkins P.M.; Zhang L.; Pei Q.; Verhey K.; Martens J.R.; Direct evidence for BBSome-associated intraflagellar transport reveals distinct properties of native mammalian cilia. Nat Commun 2014,5,5813","journal-title":"Nat Commun"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2174\/1389450117666160307143345","volume":"17","author":"Ulloa-Aguirre A.","year":"2016","unstructured":"Ulloa-Aguirre A.; Conn P.M.; Pharmacoperones as a new therapeutic approach: in vitro identification and in vivo validation of bioactive molecules. Curr Drug Targets 2016,17(13),1471-1481","journal-title":"Curr Drug Targets"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2174\/1389450117666160217123042","volume":"17","author":"Rutkowska A.","year":"2016","unstructured":"Rutkowska A.; Dev K.K.; Sailer A.W.; The role of the Oxysterol\/EBI2 pathway in the immune and central nervous systems. Curr Drug Targets 2016,17(16),1851-1860","journal-title":"Curr Drug Targets"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.2174\/0929867324666170303162416","volume":"24","author":"Liapakis G.","year":"2017","unstructured":"Liapakis G.; Matsoukas M-T.; Karageorgos V.; Venihaki M.; Mavromoustakos T.; Family B.G.; Family B G protein-coupled receptors and their ligands: from structure to function. Curr Med Chem 2017,24(31),3323-3355","journal-title":"Curr Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"Hauser A.S.","year":"2017","unstructured":"Hauser A.S.; Attwood M.M.; Rask-Andersen M.; Schi\u00f6th H.B.; Gloriam D.E.; Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 2017,16(12),829-842","journal-title":"Nat Rev Drug Discov"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archotol.128.6.635","volume":"128","author":"Temmel A.F.P.","year":"2002","unstructured":"Temmel A.F.P.; Quint C.; Schickinger-Fischer B.; Klimek L.; Stoller E.; Hummel T.; Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 2002,128(6),635-641","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/JGP.0b013e318211c205","volume":"19","author":"Gopinath B.","year":"2011","unstructured":"Gopinath B.; Anstey K.J.; Sue C.M.; Kifley A.; Mitchell P.; Olfactory impairment in older adults is associated with depressive symptoms and poorer quality of life scores. Am J Geriatr Psychiatry 2011,19(9),830-834","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/chemse\/bju043","volume":"39","author":"Philpott C.M.","year":"2014","unstructured":"Philpott C.M.; Boak D.; The impact of olfactory disorders in the United kingdom. Chem Senses 2014,39(8),711-718","journal-title":"Chem Senses"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.moo.0000193174.77321.39","volume":"14","author":"Holbrook E.H.","year":"2006","unstructured":"Holbrook E.H.; Leopold D.A.; An updated review of clinical olfaction. Curr Opin Otolaryngol Head Neck Surg 2006,14(1),23-28","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ng1418","volume":"36","author":"Kulaga H.M.","year":"2004","unstructured":"Kulaga H.M.; Leitch C.C.; Eichers E.R.; Badano J.L.; Lesemann A.; Hoskins B.E.; Lupski J.R.; Beales P.L.; Reed R.R.; Katsanis N.; Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nat Genet 2004,36(9),994-998","journal-title":"Nat Genet"},{"key":"ref=19","first-page":"15917","volume":"104","author":"McEwen D.P.","year":"2007","unstructured":"McEwen D.P.; Koenekoop R.K.; Khanna H.; Jenkins P.M.; Lopez I.; Swaroop A.; Martens J.R.; Hypomorphic CEP290\/NPHP6 mutations result in anosmia caused by the selective loss of G proteins in cilia of olfactory sensory neurons. Proc Natl Acad Sci USA 2007,104(40),15917-15922","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.1073\/pnas.1016531108","volume":"108","author":"Tadenev A.L.D.","year":"2011","unstructured":"Tadenev A.L.D.; Kulaga H.M.; May-Simera H.L.; Kelley M.W.; Katsanis N.; Reed R.R.; Loss of Bardet-Biedl syndrome protein-8 (BBS8) perturbs olfactory function, protein localization, and axon targeting. Proc Natl Acad Sci USA 2011,108(25),10320-10325","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.2860","volume":"18","author":"Mcintyre J.C.","year":"2012","unstructured":"Mcintyre J.C.; Davis E.E.; Joiner A.; Williams C.L.; Tsai I.; Jenkins P.M.; Mcewen D.P.; Zhang L.; Escobado J.; Thomas S.; Szymanska K.; Johnson C.A.; Beales P.L.; Green E.D.; Mullikin J.C.; Comparative N.; Program S.; Sabo A.; Muzny D.M.; Gibbs R.A.; Atti\u00e9-bitach T.; Yoder B.K.; Reed R.R.; Katsanis N.; Martens J.R.; Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model. Nat Med 2012,18(9),1423-1428","journal-title":"Nat Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ymthe.2017.02.006","volume":"25","author":"Williams C.L.","year":"2017","unstructured":"Williams C.L.; Uytingco C.R.; Green W.W.; McIntyre J.C.; Ukhanov K.; Zimmerman A.D.; Shively D.T.; Zhang L.; Nishimura D.Y.; Sheffield V.C.; Martens J.R.; Gene therapeutic reversal of peripheral olfactory impairment in Bardet-Biedl Syndrome. Mol Ther 2017,25(4),904-916","journal-title":"Mol Ther"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1016\/j.visres.2007.09.016","volume":"47","author":"Abd-El-Barr M.M.","year":"2007","unstructured":"Abd-El-Barr M.M.; Sykoudis K.; Andrabi S.; Eichers E.R.; Pennesi M.E.; Tan P.L.; Wilson J.H.; Katsanis N.; Lupski J.R.; Wu S.M.; Impaired photoreceptor protein transport and synaptic transmission in a mouse model of Bardet-Biedl syndrome. Vision Res 2007,47(27),3394-3407","journal-title":"Vision Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/hmg\/ddi123","volume":"14","author":"Fath M.A.","year":"2005","unstructured":"Fath M.A.; Mullins R.F.; Searby C.; Nishimura D.Y.; Wei J.; Rahmouni K.; Davis R.E.; Tayeh M.K.; Andrews M.; Yang B.; Sigmund C.D.; Stone E.M.; Sheffield V.C.; Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome. Hum Mol Genet 2005,14(9),1109-1118","journal-title":"Hum Mol Genet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"16588","DOI":"10.1073\/pnas.0405496101","volume":"101","author":"Nishimura D.Y.","year":"2004","unstructured":"Nishimura D.Y.; Fath M.; Mullins R.F.; Searby C.; Andrews M.; Davis R.; Andorf J.L.; Mykytyn K.; Swiderski R.E.; Yang B.; Carmi R.; Stone E.M.; Sheffield V.C.; Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proc Natl Acad Sci USA 2004,101(47),16588-16593","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"8664","DOI":"10.1073\/pnas.0402354101","volume":"101","author":"Mykytyn K.","year":"2004","unstructured":"Mykytyn K.; Mullins R.F.; Andrews M.; Chiang A.P.; Swiderski R.E.; Yang B.; Braun T.; Casavant T.; Stone E.M.; Sheffield V.C.; Bardet-Biedl syndrome type 4 (BBS4)-null mice implicate Bbs4 in flagella formation but not global cilia assembly. Proc Natl Acad Sci USA 2004,101(23),8664-8669","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"19422","DOI":"10.1073\/pnas.0708571104","volume":"104","author":"Davis R.E.","year":"2007","unstructured":"Davis R.E.; Swiderski R.E.; Rahmouni K.; Nishimura D.Y.; Mullins R.F.; Agassandian K.; Philp A.R.; Searby C.C.; Andrews M.P.; Thompson S.; Berry C.J.; Thedens D.R.; Yang B.; Weiss R.M.; Cassell M.D.; Stone E.M.; Sheffield V.C.; A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity. Proc Natl Acad Sci USA 2007,104(49),19422-19427","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e1000884","DOI":"10.1371\/journal.pgen.1000884","volume":"6","author":"Pretorius P.R.","year":"2010","unstructured":"Pretorius P.R.; Baye L.M.; Nishimura D.Y.; Searby C.C.; Bugge K.; Yang B.; Mullins R.F.; Stone E.M.; Sheffield V.C.; Slusarski D.C.; Identification and functional analysis of the vision-specific BBS3 (ARL6) long isoform. PLoS Genet 2010,6(3),e1000884","journal-title":"PLoS Genet"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"37483","DOI":"10.1074\/jbc.M112.386821","volume":"287","author":"Mockel A.","year":"2012","unstructured":"Mockel A.; Obringer C.; Hakvoort T.B.M.; Seeliger M.; Lamers W.H.; Stoetzel C.; Dollfus H.; Marion V.; Pharmacological modulation of the retinal unfolded protein response in Bardet-Biedl syndrome reduces apoptosis and preserves light detection ability. J Biol Chem 2012,287(44),37483-37494","journal-title":"J Biol Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"Shillingford J.M.","year":"2006","unstructured":"Shillingford J.M.; Murcia N.S.; Larson C.H.; Low S.H.; Hedgepeth R.; Brown N.; Flask C.A.; Novick A.C.; Goldfarb D.A.; Kramer-Zucker A.; Walz G.; Piontek K.B.; Germino G.G.; Weimbs T.; The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 2006,103(14),5466-5471","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/ndt\/gfi181","volume":"21","author":"Wahl P.R.","year":"2006","unstructured":"Wahl P.R.; Serra A.L.; Le Hir M.; Molle K.D.; Hall M.N.; W\u00fcthrich R.P.; Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant 2006,21(3),598-604","journal-title":"Nephrol Dial Transplant"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","volume":"132","author":"Masyuk T.V.","year":"2007","unstructured":"Masyuk T.V.; Masyuk A.I.; Torres V.E.; Harris P.C.; Larusso N.F.; Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032,5\u2032-cyclic monophosphate. Gastroenterology 2007,132(3),1104-1116","journal-title":"Gastroenterology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1093\/ndt\/gfm426","volume":"22","author":"Ibraghimov-Beskrovnaya O.","year":"2007","unstructured":"Ibraghimov-Beskrovnaya O.; Molecular pathogenesis of ADPKD and development of targeted therapeutic options. Nephrol Dial Transplant 2007,22(12),3367-3370","journal-title":"Nephrol Dial Transplant"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"c25","DOI":"10.1159\/000334166","volume":"120","author":"Chang M-Y.","year":"2012","unstructured":"Chang M-Y.; Ong A.C.M.; Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects. Nephron Clin Pract 2012,120(1),c25-c34","journal-title":"Nephron Clin Pract"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"Torres V.E.","year":"2012","unstructured":"Torres V.E.; Chapman A.B.; Devuyst O.; Gansevoort R.T.; Grantham J.J.; Higashihara E.; Perrone R.D.; Krasa H.B.; Ouyang J.; Czerwiec F.S.; Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012,367(25),2407-2418","journal-title":"N Engl J Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4172\/2157-7412.1000310","volume":"7","author":"Skalicka K.","year":"2016","unstructured":"Skalicka K.; Kovacs L.; Ciliotherapy-new opportunity for targeted therapy in autosomal dominant polycystic kidney disease. J Genet Syndr Gene Ther 2016,7(5),5-8","journal-title":"J Genet Syndr Gene Ther"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1681\/ASN.2012020154","volume":"24","author":"Sharma N.","year":"2013","unstructured":"Sharma N.; Malarkey E.B.; Berbari N.F.; O\u2019Connor A.K.; Vanden Heuvel G.B.; Mrug M.; Yoder B.K.; Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption. J Am Soc Nephrol 2013,24(3),456-464","journal-title":"J Am Soc Nephrol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.krcp.2014.05.002","volume":"33","author":"Lee S.H.","year":"2014","unstructured":"Lee S.H.; Somlo S.; Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease. Kidney Res Clin Pract 2014,33(2),73-78","journal-title":"Kidney Res Clin Pract"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/ndt\/gfm743","volume":"23","author":"Verghese E.","year":"2008","unstructured":"Verghese E.; Weidenfeld R.; Bertram J.F.; Ricardo S.D.; Deane J.A.; Renal cilia display length alterations following tubular injury and are present early in epithelial repair. Nephrol Dial Transplant 2008,23(3),834-841","journal-title":"Nephrol Dial Transplant"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1093\/ndt\/gft354","volume":"28","author":"Ong A.C.M.","year":"2013","unstructured":"Ong A.C.M.; Primary cilia and renal cysts: does length matter? Nephrol Dial Transplant 2013,28(11),2661-2663","journal-title":"Nephrol Dial Transplant"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13069-015-0024-y","volume":"8","author":"Saito S.","year":"2015","unstructured":"Saito S.; Tampe B.; M\u00fcller G.A.; Zeisberg M.; Primary cilia modulate balance of canonical and non-canonical Wnt signaling responses in the injured kidney. Fibrogenesis Tissue Repair 2015,8(1),6","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.tips.2015.11.002","volume":"37","author":"Yu F.","year":"2016","unstructured":"Yu F.; Ran J.; Zhou J.; Ciliopathies: does HDAC6 Represent a New Therapeutic Target? Trends Pharmacol Sci 2016,37(2),114-119","journal-title":"Trends Pharmacol Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1091\/mbc.e11-12-1056","volume":"23","author":"Plotnikova O.V.","year":"2012","unstructured":"Plotnikova O.V.; Nikonova A.S.; Loskutov Y.V.; Kozyu-lina P.Y.; Pugacheva E.N.; Golemis E.A.; Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis. Mol Biol Cell 2012,23(14),2658-2670","journal-title":"Mol Biol Cell"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1093\/ndt\/gft316","volume":"28","author":"Mergen M.","year":"2013","unstructured":"Mergen M.; Engel C.; M\u00fcller B.; Follo M.; Sch\u00e4fer T.; Jung M.; Walz G.; The nephronophthisis gene product NPHP2\/Inversin interacts with Aurora A and interferes with HDAC6-mediated cilia disassembly. Nephrol Dial Transplant 2013,28(11),2744-2753","journal-title":"Nephrol Dial Transplant"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1681\/ASN.2013090984","volume":"26","author":"Dere R.","year":"2015","unstructured":"Dere R.; Perkins A.L.; Bawa-Khalfe T.; Jonasch D.; Walker C.L.; \u03b2-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma. J Am Soc Nephrol 2015,26(3),553-564","journal-title":"J Am Soc Nephrol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"12917","DOI":"10.1038\/srep12917","volume":"5","author":"Ran J.","year":"2015","unstructured":"Ran J.; Yang Y.; Li D.; Liu M.; Zhou J.; Deacetylation of \u03b1-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly. Sci Rep 2015,5,12917","journal-title":"Sci Rep"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1158\/0008-5472.CAN-12-2938","volume":"73","author":"Gradilone S.A.","year":"2013","unstructured":"Gradilone S.A.; Radtke B.N.; Bogert P.S.; Huang B.Q.; Gajdos G.B.; LaRusso N.F.; HDAC6 Inhibition restores ciliary expression and decreases tumor growth. Cancer Res 2013,73(7),2259-LP-2270","journal-title":"Cancer Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/01926230490524283","volume":"32","author":"Kai K.","year":"2004","unstructured":"Kai K.; Satoh H.; Kajimura T.; Kato M.; Uchida K.; Yamaguchi R.; Tateyama S.; Furuhama K.; Olfactory epithelial lesions induced by various cancer chemotherapeutic agents in mice. Toxicol Pathol 2004,32(6),701-709","journal-title":"Toxicol Pathol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.devcel.2008.11.001","volume":"15","author":"Loktev A.V.","year":"2008","unstructured":"Loktev A.V.; Zhang Q.; Beck J.S.; Searby C.C.; Scheetz T.E.; Bazan J.F.; Slusarski D.C.; Sheffield V.C.; Jackson P.K.; Nachury M.V.; A BBSome subunit links ciliogenesis, microtubule stability, and acetylation. Dev Cell 2008,15(6),854-865","journal-title":"Dev Cell"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00795-014-0076-x","volume":"48","author":"Nakakura T.","year":"2015","unstructured":"Nakakura T.; Asano-Hoshino A.; Suzuki T.; Arisawa K.; Tanaka H.; Sekino Y.; Kiuchi Y.; Kawai K.; Hagiwara H.; The elongation of primary cilia via the acetylation of \u03b1-tubulin by the treatment with lithium chloride in human fibroblast KD cells. Med Mol Morphol 2015,48(1),44-53","journal-title":"Med Mol Morphol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.bbrc.2009.08.099","volume":"388","author":"Miyoshi K.","year":"2009","unstructured":"Miyoshi K.; Kasahara K.; Miyazaki I.; Asanuma M.; Lithium treatment elongates primary cilia in the mouse brain and in cultured cells. Biochem Biophys Res Commun 2009,388(4),757-762","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1096\/fj.15-274944","volume":"30","author":"Thompson C.L.","year":"2016","unstructured":"Thompson C.L.; Wiles A.; Poole C.A.; Knight M.M.; Lithium chloride modulates chondrocyte primary cilia and inhibits Hedgehog signaling. FASEB J 2016,30(2),716-726","journal-title":"FASEB J"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2174\/0929867324666161205130416","volume":"24","author":"Ramezani M.","year":"2017","unstructured":"Ramezani M.; Ebrahimian M.; Hashemi M.; Current strategies in the modification of PLGA-based gene delivery system. Curr Med Chem 2017,24(7),728-739","journal-title":"Curr Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.2174\/0929867322666151001121601","volume":"22","author":"Wang K.","year":"2015","unstructured":"Wang K.; Huang Q.; Qiu F.; Sui M.; Non-viral delivery systems for the application in p53 cancer gene therapy. Curr Med Chem 2015,22(35),4118-4136","journal-title":"Curr Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2174\/1389450117666160613103705","volume":"18","author":"Bhosale R.R.","year":"2017","unstructured":"Bhosale R.R.; Gangadharappa H.V.; Hani U.; Ali M.; Osmani R.; Vaghela R.; Kulkarni P.K.; Koganti V.S.; Current perspectives on novel drug delivery systems and therapies for management of prostate cancer: an inclusive review. Curr Drug Targets 2017,18(11),1233-1249","journal-title":"Curr Drug Targets"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1089\/hum.2004.15.1157","volume":"15","author":"Muruve D.A.","year":"2004","unstructured":"Muruve D.A.; The innate immune response to adenovirus vectors. Hum Gene Ther 2004,15(12),1157-1166","journal-title":"Hum Gene Ther"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.gt.3303085","volume":"15","author":"Huang D.","year":"2008","unstructured":"Huang D.; Pereboev A.V.; Korokhov N.; He R.; Larocque L.; Gravel C.; Jaentschke B.; Tocchi M.; Casley W.L.; Lemieux M.; Curiel D.T.; Chen W.; Li X.; Significant alterations of biodistribution and immune responses in Balb\/c mice administered with adenovirus targeted to CD40(+) cells. Gene Ther 2008,15(4),298-308","journal-title":"Gene Ther"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"18794","DOI":"10.1074\/jbc.M109.090662","volume":"285","author":"Sammels E.","year":"2010","unstructured":"Sammels E.; Devogelaere B.; Mekahli D.; Bultynck G.; Missiaen L.; Parys J.B.; Cai Y.; Somlo S.; De Smedt H.; Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J Biol Chem 2010,285(24),18794-18805","journal-title":"J Biol Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ki.2008.395","volume":"74","author":"Wei F.","year":"2008","unstructured":"Wei F.; Karihaloo A.; Yu Z.; Marlier A.; Seth P.; Shibazaki S.; Wang T.; Sukhatme V.P.; Somlo S.; Cantley L.G.; Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo. Kidney Int 2008,74(10),1310-1318","journal-title":"Kidney Int"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"9254","DOI":"10.1074\/jbc.M113.514166","volume":"289","author":"Park E.Y.","year":"2014","unstructured":"Park E.Y.; Kim B.H.; Lee E.J.; Chang E.; Kim D.W.; Choi S.Y.; Park J.H.; Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease. J Biol Chem 2014,289(13),9254-9262","journal-title":"J Biol Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/(SICI)1097-4695(199608)30:4<521:AID-NEU7>3.0.CO;2-5","volume":"30","author":"Zhao H.","year":"1996","unstructured":"Zhao H.; Otaki J.M.; Firestein S.; Adenovirus-mediated gene transfer in olfactory neurons in vivo. J Neurobiol 1996,30(4),521-530","journal-title":"J Neurobiol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0169-328X(96)00085-X","volume":"41","author":"Holtmaat A.J.G.D.","year":"1996","unstructured":"Holtmaat A.J.G.D.; Hermens W.T.J.M.C.; Oestreicher A.B.; Gispen W.H.; Kaplitt M.G.; Verhaagen J.; Efficient adenoviral vector-directed expression of a foreign gene to neurons and sustentacular cells in the mouse olfactory neuroepithelium. Brain Res Mol Brain Res 1996,41(1-2),148-156","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1073\/pnas.96.7.4040","volume":"96","author":"Touhara K.","year":"1999","unstructured":"Touhara K.; Sengoku S.; Inaki K.; Tsuboi A.; Hirono J.; Sato T.; Sakano H.; Haga T.; Functional identification and reconstitution of an odorant receptor in single olfactory neurons. Proc Natl Acad Sci USA 1999,96(7),4040-4045","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/80632","volume":"3","author":"Ivic L.","year":"2000","unstructured":"Ivic L.; Pyrski M.M.; Margolis J.W.; Richards L.J.; Firestein S.; Margolis F.L.; Adenoviral vector-mediated rescue of the OMP-null phenotype in vivo. Nat Neurosci 2000,3(11),1113-1120","journal-title":"Nat Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/000164802320396303","volume":"122","author":"Arimoto Y.","year":"2002","unstructured":"Arimoto Y.; Nagata H.; Isegawa N.; Kumahara K.; Isoyama K.; Konno A.; Shirasawa H.; In vivo expression of adenovirus-mediated lacZ gene in murine nasal mucosa. Acta Otolaryngol 2002,122(6),627-633","journal-title":"Acta Otolaryngol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/neu.10016","volume":"50","author":"Ivic L.","year":"2002","unstructured":"Ivic L.; Zhang C.; Zhang X.; Yoon S.O.; Firestein S.; Intracellular trafficking of a tagged and functional mammalian olfactory receptor. J Neurobiol 2002,50(1),56-68","journal-title":"J Neurobiol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1037\/0735-7044.118.3.636","volume":"118","author":"Youngentob S.L.","year":"2004","unstructured":"Youngentob S.L.; Pyrski M.M.; Margolis F.L.; Adenoviral vector-mediated rescue of the OMP-null behavioral phenotype: enhancement of odorant threshold sensitivity. Behav Neurosci 2004,118(3),636-642","journal-title":"Behav Neurosci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11068-005-8359-8","volume":"34","author":"Venkatraman G.","year":"2005","unstructured":"Venkatraman G.; Behrens M.; Pyrski M.; Margolis F.L.; Expression of coxsackie-adenovirus receptor (CAR) in the developing mouse olfactory system. J Neurocytol 2005,34(3-5),295-305","journal-title":"J Neurocytol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/gt.2010.153","volume":"18","author":"Gau P.","year":"2011","unstructured":"Gau P.; Rodriguez S.; De Leonardis C.; Chen P.; Lin D.M.; Air-assisted intranasal instillation enhances adenoviral delivery to the olfactory epithelium and respiratory tract. Gene Ther 2011,18(5),432-436","journal-title":"Gene Ther"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","volume":"77","author":"Lemiale F.","year":"2003","unstructured":"Lemiale F.; Kong W.P.; Aky\u00fcrek L.M.; Ling X.; Huang Y.; Chakrabarti B.K.; Eckhaus M.; Nabel G.J.; Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol 2003,77(18),10078-10087","journal-title":"J Virol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1479-0556-6-5","volume":"6","author":"Damjanovic D.","year":"2008","unstructured":"Damjanovic D.; Zhang X.; Mu J.; Fe Medina M.; Xing Z.; Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector. Genet Vaccines Ther 2008,6,5","journal-title":"Genet Vaccines Ther"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/000348940511400808","volume":"114","author":"Doi K.","year":"2005","unstructured":"Doi K.; Nibu K.; Ishida H.; Okado H.; Terashima T.; Adenovirus-mediated gene transfer in olfactory epithelium and olfactory bulb: a long-term study. Ann Otol Rhinol Laryngol 2005,114(8),629-633","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"Zincarelli C.","year":"2008","unstructured":"Zincarelli C.; Soltys S.; Rengo G.; Rabinowitz J.E.; Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 2008,16(6),1073-1080","journal-title":"Mol Ther"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1002\/j.1460-2075.1991.tb04964.x","volume":"10","author":"Samulski R.J.","year":"1991","unstructured":"Samulski R.J.; Zhu X.; Xiao X.; Brook J.D.; Housman D.E.; Epstein N.; Hunter L.A.; Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 1991,10(12),3941-3950","journal-title":"EMBO J"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jhered\/esg015","volume":"94","author":"Narfstr\u00f6m K.","year":"2003","unstructured":"Narfstr\u00f6m K.; Katz M.L.; Ford M.; Redmond T.M.; Rakoczy E.; Bragad\u00f3ttir R.; In vivo gene therapy in young and adult RPE65-\/- dogs produces long-term visual improvement. J Hered 2003,94(1),31-37","journal-title":"J Hered"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1167\/iovs.02-0595","volume":"44","author":"Narfstr\u00f6m K.","year":"2003","unstructured":"Narfstr\u00f6m K.; Katz M.L.; Bragadottir R.; Seeliger M.; Boulanger A.; Redmond T.M.; Caro L.; Lai C.M.; Rakoczy P.E.; Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci 2003,44(4),1663-1672","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/sj.gt.3302861","volume":"14","author":"Le Meur G.","year":"2007","unstructured":"Le Meur G.; Stieger K.; Smith A.J.; Weber M.; Deschamps J.Y.; Nivard D.; Mendes-Madeira A.; Provost N.; P\u00e9r\u00e9on Y.; Cherel Y.; Ali R.R.; Hamel C.; Moullier P.; Rolling F.; Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther 2007,14(4),292-303","journal-title":"Gene Ther"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","volume":"12","author":"Acland G.M.","year":"2005","unstructured":"Acland G.M.; Aguirre G.D.; Bennett J.; Aleman T.S.; Cideciyan A.V.; Bennicelli J.; Dejneka N.S.; Pearce-Kelling S.E.; Maguire A.M.; Palczewski K.; Hauswirth W.W.; Jacobson S.G.; Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 2005,12(6),1072-1082","journal-title":"Mol Ther"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","volume":"358","author":"Bainbridge J.W.B.","year":"2008","unstructured":"Bainbridge J.W.B.; Smith A.J.; Barker S.S.; Robbie S.; Henderson R.; Balaggan K.; Viswanathan A.; Holder G.E.; Stockman A.; Tyler N.; Petersen-Jones S.; Bhattacharya S.S.; Thrasher A.J.; Fitzke F.W.; Carter B.J.; Rubin G.S.; Moore A.T.; Ali R.R.; Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis. N Engl J Med 2008,358(21),2231-2239","journal-title":"N Engl J Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"E517","DOI":"10.1073\/pnas.1218933110","volume":"110","author":"Cideciyan A.V.","year":"2013","unstructured":"Cideciyan A.V.; Jacobson S.G.; Beltran W.A.; Sumaroka A.; Swider M.; Iwabe S.; Roman A.J.; Olivares M.B.; Schwartz S.B.; Kom\u00e1romy A.M.; Hauswirth W.W.; Aguirre G.D.; Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci USA 2013,110(6),E517-E525","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","volume":"372","author":"Bainbridge J.W.B.","year":"2015","unstructured":"Bainbridge J.W.B.; Mehat M.S.; Sundaram V.; Robbie S.J.; Barker S.E.; Ripamonti C.; Georgiadis A.; Mowat F.M.; Beattie S.G.; Gardner P.J.; Feathers K.L.; Luong V.A.; Yzer S.; Balaggan K.; Viswanathan A.; de Ravel T.J.L.; Casteels I.; Holder G.E.; Tyler N.; Fitzke F.W.; Weleber R.G.; Nardini M.; Moore A.T.; Thompson D.A.; Petersen-Jones S.M.; Michaelides M.; van den Born L.I.; Stockman A.; Smith A.J.; Rubin G.; Ali R.R.; Long-term effect of gene therapy on Leber\u2019s congenital amaurosis. N Engl J Med 2015,372(20),1887-1897","journal-title":"N Engl J Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1073\/pnas.1019222108","volume":"108","author":"Simons D.L.","year":"2011","unstructured":"Simons D.L.; Boye S.L.; Hauswirth W.W.; Wu S.M.; Gene therapy prevents photoreceptor death and preserves retinal function in a Bardet-Biedl syndrome mouse model. Proc Natl Acad Sci USA 2011,108(15),6276-6281","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1167\/iovs.13-11673","volume":"54","author":"Seo S.","year":"2013","unstructured":"Seo S.; Mullins R.F.; Dumitrescu A.V.; Bhattarai S.; Gratie D.; Wang K.; Stone E.M.; Sheffield V.; Drack A.V.; Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1. Invest Ophthalmol Vis Sci 2013,54(9),6118-6132","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"12993","DOI":"10.1073\/pnas.0601433103","volume":"103","author":"Limberis M.P.","year":"2006","unstructured":"Limberis M.P.; Wilson J.M.; Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc Natl Acad Sci USA 2006,103(35),12993-12998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/mt.2008.261","volume":"17","author":"Limberis M.P.","year":"2009","unstructured":"Limberis M.P.; Vandenberghe L.H.; Zhang L.; Pickles R.J.; Wilson J.M.; Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 2009,17(2),294-301","journal-title":"Mol Ther"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ncomms2013","volume":"3","author":"Cao L.","year":"2012","unstructured":"Cao L.; Schrank B.R.; Rodriguez S.; Benz E.G.; Moulia T.W.; Rickenbacher G.T.; Gomez A.C.; Levites Y.; Edwards S.R.; Golde T.E.; Hyman B.T.; Barnea G.; Albers M.W.; A\u03b2 alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun 2012,3,1009","journal-title":"Nat Commun"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/gt.2014.39","volume":"21","author":"Burnight E.R.","year":"2014","unstructured":"Burnight E.R.; Wiley L.A.; Drack A.V.; Braun T.A.; Anfinson K.R.; Kaalberg E.E.; Halder J.A.; Affatigato L.M.; Mullins R.F.; Stone E.M.; Tucker B.A.; CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype. Gene Ther 2014,21(7),662-672","journal-title":"Gene Ther"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/gt.2013.79","volume":"21","author":"Ostrowski L.E.","year":"2014","unstructured":"Ostrowski L.E.; Yin W.; Patel M.; Sechelski J.; Rogers T.; Burns K.; Grubb B.R.; Olsen J.C.; Restoring ciliary function to differentiated primary ciliary dyskinesia cells with a lentiviral vector. Gene Ther 2014,21(3),253-261","journal-title":"Gene Ther"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"e1000422","DOI":"10.1371\/journal.pgen.1000422","volume":"5","author":"Chhin B.","year":"2009","unstructured":"Chhin B.; Negre D.; Merrot O.; Pham J.; Tourneur Y.; Ressnikoff D.; Jaspers M.; Jorissen M.; Cosset F.L.; Bouvagnet P.; Ciliary beating recovery in deficient human airway epithelial cells after lentivirus ex vivo gene therapy. PLoS Genet 2009,5(3),e1000422","journal-title":"PLoS Genet"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"12818","DOI":"10.1128\/JVI.79.20.12818-12827.2005","volume":"79","author":"Sinn P.L.","year":"2005","unstructured":"Sinn P.L.; Burnight E.R.; Hickey M.A.; Blissard G.W.; McCray P.B.; Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol 2005,79(20),12818-12827","journal-title":"J Virol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1749-8104-3-22","volume":"3","author":"Chen H.","year":"2008","unstructured":"Chen H.; Dadsetan S.; Fomina A.F.; Gong Q.; Expressing exogenous functional odorant receptors in cultured olfactory sensory neurons. Neural Dev 2008,3(1),22","journal-title":"Neural Dev"},{"key":"ref=92","first-page":"5","volume":"51","author":"Sadrian B.","year":"2011","unstructured":"Sadrian B.; Chen H.; Gong Q.; Lentivirus-mediated genetic manipulation and visualization of olfactory sensory neurons in vivo. J Vis Exp 2011,51,5-8","journal-title":"J Vis Exp"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1128\/JVI.00227-08","volume":"82","author":"Sinn P.L.","year":"2008","unstructured":"Sinn P.L.; Arias A.C.; Brogden K.A.; McCray P.B.; Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J Virol 2008,82(21),10684-10692","journal-title":"J Virol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nmeth.2331","volume":"10","author":"Ranzani M.","year":"2013","unstructured":"Ranzani M.; Cesana D.; Bartholomae C.C.; Sanvito F.; Pala M.; Benedicenti F.; Gallina P.; Sergi L.S.; Merella S.; Bulfone A.; Doglioni C.; von Kalle C.; Kim Y.J.; Schmidt M.; Tonon G.; Naldini L.; Montini E.; Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer. Nat Methods 2013,10(2),155-161","journal-title":"Nat Methods"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/gt.2012.88","volume":"20","author":"Papayannakos C.","year":"2013","unstructured":"Papayannakos C.; Daniel R.; Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy. Gene Ther 2013,20(6),581-588","journal-title":"Gene Ther"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2174\/1389450117666160527142321","volume":"18","author":"Chakraborty C.","year":"2017","unstructured":"Chakraborty C.; Teoh S.L.; Das S.; The smart programmable CRISPR technology: A next generation genome editing tool for investigators. Curr Drug Targets 2017,18(14),1653-1663","journal-title":"Curr Drug Targets"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijpharm.2015.08.029","volume":"494","author":"LaFountaine J.S.","year":"2015","unstructured":"LaFountaine J.S.; Fathe K.; Smyth H.D.C.; Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR\/Cas9. Int J Pharm 2015,494(1),180-194","journal-title":"Int J Pharm"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/biores.2012.0218","volume":"1","author":"Lee C.M.","year":"2012","unstructured":"Lee C.M.; Flynn R.; Hollywood J.A.; Scallan M.F.; Harrison P.T.; Correction of the \u0394F508 mutation in the cystic fibrosis transmembrane conductance regulator gene by zinc-finger nuclease homology-directed repair. Biores Open Access 2012,1(3),99-108","journal-title":"Biores Open Access"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stemcr.2015.02.005","volume":"4","author":"Crane A.M.","year":"2015","unstructured":"Crane A.M.; Kramer P.; Bui J.H.; Chung W.J.; Li X.S.; Gonzalez-Garay M.L.; Hawkins F.; Liao W.; Mora D.; Choi S.; Wang J.; Sun H.C.; Paschon D.E.; Guschin D.Y.; Gregory P.D.; Kotton D.N.; Holmes M.C.; Sorscher E.J.; Davis B.R.; Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells. Stem Cell Reports 2015,4(4),569-577","journal-title":"Stem Cell Reports"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/jmedgenet-2015-103539","volume":"53","author":"Lai M.","year":"2016","unstructured":"Lai M.; Pifferi M.; Bush A.; Piras M.; Michelucci A.; Di Cicco M.; del Grosso A.; Quaranta P.; Cursi C.; Tantillo E.; Franceschi S.; Mazzanti M.C.; Simi P.; Saggese G.; Boner A.; Pistello M.; Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia. J Med Genet 2016,53(4),242-249","journal-title":"J Med Genet"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","volume":"25","author":"Ruan G.X.","year":"2017","unstructured":"Ruan G.X.; Barry E.; Yu D.; Lukason M.; Cheng S.H.; Scaria A.; CRISPR\/Cas9-mediated genome editing as a therapeutic approach for leber congenital amaurosis 10. Mol Ther 2017,25(2),331-341","journal-title":"Mol Ther"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ibmb.2016.10.003","volume":"79","author":"Li Y.","year":"2016","unstructured":"Li Y.; Zhang J.; Chen D.; Yang P.; Jiang F.; Wang X.; Kang L.; CRISPR\/Cas9 in locusts: Successful establishment of an olfactory deficiency line by targeting the mutagenesis of an odorant receptor co-receptor (Orco). Insect Biochem Mol Biol 2016,79,27-35","journal-title":"Insect Biochem Mol Biol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"29620","DOI":"10.1038\/srep29620","volume":"6","author":"Koutroumpa F.A.","year":"2016","unstructured":"Koutroumpa F.A.; Monsempes C.; Fran\u00e7ois M-C.; de Cian A.; Royer C.; Concordet J-P.; Jacquin-Joly E.; Heritable genome editing with CRISPR\/Cas9 induces anosmia in a crop pest moth. Sci Rep 2016,6(1),29620","journal-title":"Sci Rep"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cell.2017.07.001","volume":"170","author":"Trible W.","year":"2017","unstructured":"Trible W.; Olivos-Cisneros L.; McKenzie S.K.; Saragosti J.; Chang N-C.; Matthews B.J.; Oxley P.R.; Kronauer D.J.C.; Orco mutagenesis causes loss of antennal lobe glomeruli and impaired social behavior in ants. Cell 2017,170(4),727-735.e10","journal-title":"Cell"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cell.2017.06.051","volume":"170","author":"Yan H.","year":"2017","unstructured":"Yan H.; Opachaloemphan C.; Mancini G.; Yang H.; Gallitto M.; Mlejnek J.; Leibholz A.; Haight K.; Ghaninia M.; Huo L.; Perry M.; Slone J.; Zhou X.; Traficante M.; Penick C.A.; Dolezal K.; Gokhale K.; Stevens K.; Fetter-Pruneda I.; Bonasio R.; Zwiebel L.J.; Berger S.L.; Liebig J.; Reinberg D.; Desplan C.; An engineered orco mutation produces aberrant social behavior and defective neural development in ants. Cell 2017,170(4),736-747.e9","journal-title":"Cell"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0166-2236(90)90017-5","volume":"13","author":"Farbman A.I.","year":"1990","unstructured":"Farbman A.I.; Olfactory neurogenesis: genetic or environmental controls? Trends Neurosci 1990,13(9),362-365","journal-title":"Trends Neurosci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1460-9568.1991.tb00081.x","volume":"3","author":"Mackay-Sim A.","year":"1991","unstructured":"Mackay-Sim A.; Kittel P.W.; On the life span of olfactory receptor neurons. Eur J Neurosci 1991,3(3),209-215","journal-title":"Eur J Neurosci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1097\/00001756-199805110-00065","volume":"9","author":"Goldstein B.J.","year":"1998","unstructured":"Goldstein B.J.; Fang H.; Youngentob S.L.; Schwob J.E.; Transplantation of multipotent progenitors from the adult olfactory epithelium. Neuroreport 1998,9(7),1611-1617","journal-title":"Neuroreport"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/cne.11031","volume":"469","author":"Chen X.","year":"2004","unstructured":"Chen X.; Fang H.; Schwob J.E.; Multipotency of purified, transplanted globose basal cells in olfactory epithelium. J Comp Neurol 2004,469(4),457-474","journal-title":"J Comp Neurol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"E5068","DOI":"10.1073\/pnas.1512272112","volume":"112","author":"Schnittke N.","year":"2015","unstructured":"Schnittke N.; Herrick D.B.; Lin B.; Peterson J.; Coleman J.H.; Packard A.I.; Jang W.; Schwob J.E.; Transcription factor p63 controls the reserve status but not the stemness of horizontal basal cells in the olfactory epithelium. Proc Natl Acad Sci USA 2015,112(36),E5068-E5077","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/lary.20101","volume":"119","author":"Hummel T.","year":"2009","unstructured":"Hummel T.; Rissom K.; Reden J.; H\u00e4hner A.; Weidenbecher M.; H\u00fcttenbrink K-B.; Effects of olfactory training in patients with olfactory loss. Laryngoscope 2009,119(3),496-499","journal-title":"Laryngoscope"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2500\/ajra.2017.31.4466","volume":"31","author":"Jiang R.S.","year":"2017","unstructured":"Jiang R.S.; Twu C.W.; Liang K.L.; The effect of olfactory training on the odor threshold in patients with traumatic anosmia. Am J Rhinol Allergy 2017,31(5),317-322","journal-title":"Am J Rhinol Allergy"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/lary.24340","volume":"124","author":"Damm M.","year":"2014","unstructured":"Damm M.; Pikart L.K.; Reimann H.; Burkert S.; G\u00f6ktas \u00d6.; Haxel B.; Frey S.; Charalampakis I.; Beule A.; Renner B.; Hummel T.; H\u00fcttenbrink K.B.; Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope 2014,124(4),826-831","journal-title":"Laryngoscope"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4193\/Rhin15.264","volume":"54","author":"Konstantinidis I.","year":"2016","unstructured":"Konstantinidis I.; Tsakiropoulou E.; Constantinidis J.; Long term effects of olfactory training in patients with post-infectious olfactory loss. Rhinology 2016,54(2),170-175","journal-title":"Rhinology"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"140419","DOI":"10.1155\/2014\/140419","volume":"2014","author":"Kollndorfer K.","year":"2014","unstructured":"Kollndorfer K.; Kowalczyk K.; Hoche E.; Mueller C.A.; Pollak M.; Trattnig S.; Sch\u00f6pf V.; Recovery of olfactory function induces neuroplasticity effects in patients with smell loss. Neural Plast 2014,2014,140419","journal-title":"Neural Plast"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"e19919","DOI":"10.1371\/journal.pone.0019919","volume":"6","author":"Hida K.","year":"2011","unstructured":"Hida K.; Lai S.K.; Suk J.S.; Won S.Y.; Boyle M.P.; Hanes J.; Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients. PLoS One 2011,6(5),e19919","journal-title":"PLoS One"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/sj.gt.3300840","volume":"6","author":"Kitson C.","year":"1999","unstructured":"Kitson C.; Angel B.; Judd D.; Rothery S.; Severs N.J.; Dewar, a; Huang, L.; Wadsworth, S. C.; Cheng, S. H.; Geddes, D. M.; Alton, E. W. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther 1999,6(4),534-546","journal-title":"Gene Ther"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJM199509283331302","volume":"333","author":"Knowles M.R.","year":"1995","unstructured":"Knowles M.R.; Hohneker K.W.; Zhou Z.; Olsen J.C.; Noah T.L.; Hu P.C.; Leigh M.W.; Engelhardt J.F.; Edwards L.J.; Jones K.R.; A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 1995,333(13),823-831","journal-title":"N Engl J Med"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cell.2011.09.014","volume":"147","author":"Novarino G.","year":"2011","unstructured":"Novarino G.; Akizu N.; Gleeson J.G.; Modeling human disease in humans: the ciliopathies. Cell 2011,147(1),70-79","journal-title":"Cell"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1126\/science.1063525","volume":"293","author":"Katsanis N.","year":"2001","unstructured":"Katsanis N.; Triallelic inheritance in Bardet-Biedl syndrome, a mendelian recessive Disorder. Science 2001,293(5538),2256-2259","journal-title":"Science"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1086\/341031","volume":"71","author":"Katsanis N.","year":"2002","unstructured":"Katsanis N.; Eichers E.R.; Ansley S.J.; Lewis R.A.; Kayserili H.; Hoskins B.E.; Scambler P.J.; Beales P.L.; Lupski J.R.; BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance. Am J Hum Genet 2002,71(1),22-29","journal-title":"Am J Hum Genet"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1089\/104303401750298535","volume":"12","author":"Joseph P.M.","year":"2001","unstructured":"Joseph P.M.; O\u2019Sullivan B.P.; Lapey A.; Dorkin H.; Oren J.; Balfour R.; Perricone M.A.; Rosenberg M.; Wadsworth S.C.; Smith A.E.; St George J.A.; Meeker D.P.; Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications. Hum Gene Ther 2001,12(11),1369-1382","journal-title":"Hum Gene Ther"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","volume":"122","author":"Mingozzi F.","year":"2013","unstructured":"Mingozzi F.; High K.A.; Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 2013,122(1),23-36","journal-title":"Blood"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/cge.12391","volume":"86","author":"Braun J.J.","year":"2014","unstructured":"Braun J.J.; Noblet V.; Durand M.; Scheidecker S.; Zinetti-Bertschy A.; Foucher J.; Marion V.; Muller J.; Riehm S.; Dollfus H.; Kremer S.; Olfaction evaluation and correlation with brain atrophy in Bardet-Biedl syndrome. Clin Genet 2014,86(6),521-529","journal-title":"Clin Genet"},{"key":"ref=125","first-page":"343-346","volume":"132 A","author":"Iannaccone A.","year":"2005","unstructured":"Iannaccone A.; Mykytyn K.; Persico A. M.; Searby C. C.; Baldi A.; Jablonski M. M.; Sheffield V. C.; Clinical evidence of decreased olfaction in bardet-biedl syndrome caused by a deletion in the BBS4 gene. Am J Med Genet 2005,132 A(4),343-346","journal-title":"Am J Med Genet"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/humu.21337","volume":"31","author":"Coppieters F.","year":"2010","unstructured":"Coppieters F.; Lefever S.; Leroy B.P.; De Baere E.; CEP290, a gene with many faces: mutation overview and presentation of CEP290base. Hum Mutat 2010,31(10),1097-1108","journal-title":"Hum Mutat"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00005072-199011000-00007","volume":"49","author":"Ahdab-Barmada M.","year":"1990","unstructured":"Ahdab-Barmada M.; Claassen D.; A distinctive triad of malformations of the central nervous system in the Meckel-Gruber syndrome. J Neuropathol Exp Neurol 1990,49(6),610-620","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"e19694","DOI":"10.1371\/journal.pone.0019694","volume":"6","author":"Pluznick J.L.","year":"2011","unstructured":"Pluznick J.L.; Rodriguez-Gil D.J.; Hull M.; Mistry K.; Gattone V.; Johnson C.A.; Weatherbee S.; Greer C.A.; Caplan M.J.; Renal cystic disease proteins play critical roles in the organization of the olfactory epithelium. PLoS One 2011,6(5),e19694","journal-title":"PLoS One"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/hmg\/ddl107","volume":"15","author":"Chang B.","year":"2006","unstructured":"Chang B.; Khanna H.; Hawes N.; Jimeno D.; He S.; Lillo C.; Parapuram S.K.; Cheng H.; Scott A.; Hurd R.E.; Sayer J.A.; Otto E.A.; Attanasio M.; O\u2019Toole J.F.; Jin G.; Shou C.; Hildebrandt F.; Williams D.S.; Heckenlively J.R.; Swaroop A.; In-frame deletion in a novel centrosomal\/ciliary protein CEP290\/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse. Hum Mol Genet 2006,15(11),1847-1857","journal-title":"Hum Mol Genet"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.devcel.2007.03.004","volume":"12","author":"Caspary T.","year":"2007","unstructured":"Caspary T.; Larkins C.E.; Anderson K.V.; The graded response to Sonic Hedgehog depends on cilia architecture. Dev Cell 2007,12(5),767-778","journal-title":"Dev Cell"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1242\/dev.01240","volume":"131","author":"Sun Z.","year":"2004","unstructured":"Sun Z.; Amsterdam A.; Pazour G.J.; Cole D.G.; Miller M.S.; Hopkins N.; A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 2004,131(16),4085-4093","journal-title":"Development"},{"key":"ref=132","first-page":"1334","volume":"2004","author":"Gibberd F.B.","year":"2005","unstructured":"Gibberd F.B.; Feher M.D.; Sidey M.C.; Wierzbicki, a S. Smell testing: an additional tool for identification of adult refsum\u2019s disease. J Neurol Neurosurg Psychiatry 2005,2004(75),1334-1336","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/j.0022-3042.2002.00766.x","volume":"80","author":"Wierzbicki A.S.","year":"2002","unstructured":"Wierzbicki A.S.; Lloyd M.D.; Schofield C.J.; Feher M.D.; Gibberd F.B.; Refsum\u2019s disease: a peroxisomal disorder affecting phytanic acid \u03b1-oxidation. J Neurochem 2002,80(5),727-735","journal-title":"J Neurochem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000027594","volume":"60","author":"Abdel-Hak B.","year":"1998","unstructured":"Abdel-Hak B.; Gunkel A.; Kanonier G.; Schrott-Fischer A.; Ulmer H.; Thumfart W.; Ciliary beat frequency, olfaction and endoscopic sinus surgery. ORL J Otorhinolaryngol Relat Spec 1998,60(4),202-205","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/jmg.2010.077883","volume":"47","author":"Papon J.F.","year":"2010","unstructured":"Papon J.F.; Perrault I.; Coste A.; Louis B.; G\u00e9rard X.; Hanein S.; Fares-Taie L.; Gerber S.; Defoort-Dhelle-mmes S.; Vojtek A.M.; Kaplan J.; Rozet J.M.; Escudier E.; Abnormal respiratory cilia in non-syndromic Leber congenital amaurosis with CEP290 mutations. J Med Genet 2010,47(12),829-834","journal-title":"J Med Genet"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/ajmg.a.33416","volume":"152A","author":"Lehman A.M.","year":"2010","unstructured":"Lehman A.M.; Eydoux P.; Doherty D.; Glass I.A.; Chitayat D.; Chung B.Y.H.; Langlois S.; Yong S.L.; Lowry R.B.; Hildebrandt F.; Trnka P.; Co-occurrence of Joubert syndrome and Jeune asphyxiating thoracic dystrophy. Am J Med Genet A 2010,152A(6),1411-1419","journal-title":"Am J Med Genet A"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s12020-015-0690-y","volume":"52","author":"Maione L.","year":"2016","unstructured":"Maione L.; Cantone E.; Nettore I.C.; Cerbone G.; De Brasi D.; Maione N.; Young J.; Di Somma C.; Sinisi A.A.; Iengo M.; Macchia P.E.; Pivonello R.; Colao A.; Flavor perception test: evaluation in patients with Kallmann syndrome. Endocrine 2016,52(2),236-243","journal-title":"Endocrine"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000328437","volume":"94","author":"Koenigkam-Santos M.","year":"2011","unstructured":"Koenigkam-Santos M.; Santos A.C.; Versiani B.R.; Diniz P.R.B.; Junior J.E.; de Castro M.; Quantitative magnetic resonance imaging evaluation of the olfactory system in Kallmann syndrome: correlation with a clinical smell test. Neuroendocrinology 2011,94(3),209-217","journal-title":"Neuroendocrinology"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fendo.2013.00019","volume":"4","author":"Dod\u00e9 C.","year":"2013","unstructured":"Dod\u00e9 C.; Rondard P.; PROK2\/PROKR2 Signaling and Kallmann Syndrome. Front Endocrinol (Lausanne) 2013,4,19","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=140","first-page":"249","volume":"22","author":"Mitchell A.L.","year":"2011","unstructured":"Mitchell A.L.; Dwyer A.; Pitteloud N.; Quinton R.; Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab 2011,22(7),249-258","journal-title":"Trends Endocrinol Metab"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1210\/jc.2002-021491","volume":"88","author":"Bojesen A.","year":"2003","unstructured":"Bojesen A.; Juul S.; Gravholt C.H.; Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab 2003,88(2),622-626","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"E136","DOI":"10.1210\/jc.2011-2041","volume":"97","author":"Lewkowitz-Shpuntoff H.M.","year":"2012","unstructured":"Lewkowitz-Shpuntoff H.M.; Hughes V.A.; Plummer L.; Au M.G.; Doty R.L.; Seminara S.B.; Chan Y.M.; Pitteloud N.; Crowley W.F.; Balasubramanian R.; Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab 2012,97(1),E136-E144","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MCD.0b013e328306a704","volume":"17","author":"Vuorela P.E.","year":"2008","unstructured":"Vuorela P.E.; Penttinen M.T.; Hietala M.H.; Laine J.O.; Huoponen K.A.; K\u00e4ri\u00e4inen H.A.; A familial CHARGE syndrome with a CHD7 nonsense mutation and new clinical features. Clin Dysmorphol 2008,17(4),249-253","journal-title":"Clin Dysmorphol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1399-0004.2008.01107.x","volume":"75","author":"Jongmans M.C.J.","year":"2009","unstructured":"Jongmans M.C.J.; van Ravenswaaij-Arts C.M.A.; Pitteloud N.; Ogata T.; Sato N.; Claahsen-van der Grinten H.L.; van der Donk K.; Seminara S.; Bergman J.E.H.; Brunner H.G.; Crowley W.F.; Hoefsloot L.H.; CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome. Clin Genet 2009,75(1),65-71","journal-title":"Clin Genet"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/hmg\/ddv490","volume":"25","author":"Jansen F.","year":"2016","unstructured":"Jansen F.; Kalbe B.; Scholz P.; Mikosz M.; Wunderlich K.A.; Kurtenbach S.; Nagel-Wolfrum K.; Wolfrum U.; Hatt H.; Osterloh S.; Impact of the Usher syndrome on olfaction. Hum Mol Genet 2016,25(3),524-533","journal-title":"Hum Mol Genet"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s004170050237","volume":"237","author":"Seeliger M.","year":"1999","unstructured":"Seeliger M.; Pfister M.; Gendo K.; Paasch S.; Apfelstedt-Sylla E.; Plinkert P.; Zenner H-P.; Zrenner E.; Comparative study of visual, auditory, and olfactory function in Usher syndrome. Graefes Arch Clin Exp Ophthalmol 1999,237(4),301-307","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"28309","DOI":"10.1038\/srep28309","volume":"6","author":"Ribeiro J.C.","year":"2016","unstructured":"Ribeiro J.C.; Oliveiros B.; Pereira P.; Ant\u00f3nio N.; Hummel T.; Paiva A.; Silva E.D.; Accelerated age-related olfactory decline among type 1 Usher patients. Sci Rep 2016,6(1),28309","journal-title":"Sci Rep"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/000348949710600206","volume":"106","author":"Marietta J.","year":"1997","unstructured":"Marietta J.; Walters K.S.; Burgess R.; Ni L.; Fukushima K.; Moore K.C.; Hejtmancik J.F.; Smith R.J.H.; Usher\u2019s syndrome type IC: clinical studies and fine-mapping the disease locus. Ann Otol Rhinol Laryngol 1997,106(2),123-128","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.exer.2005.11.010","volume":"83","author":"Reiners J.","year":"2006","unstructured":"Reiners J.; Nagel-Wolfrum K.; J\u00fcrgens K.; M\u00e4rker T.; Wolfrum U.; Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res 2006,83(1),97-119","journal-title":"Exp Eye Res"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ydbio.2010.01.017","volume":"340","author":"Endoh-Yamagami S.","year":"2010","unstructured":"Endoh-Yamagami S.; Karkar K.M.; May S.R.; Cobos I.; Thwin M.T.; Long J.E.; Ashique A.M.; Zarbalis K.; Rubenstein J.L.R.; Peterson A.S.; A mutation in the pericentrin gene causes abnormal interneuron migration to the olfactory bulb in mice. Dev Biol 2010,340(1),41-53","journal-title":"Dev Biol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/BF00687219","volume":"74","author":"Hori A.","year":"1987","unstructured":"Hori A.; Tamagawa K.; Eber S.W.; Westmeier M.; Hansmann I.; Neuropathology of Seckel syndrome in fetal stage with evidence of intrauterine developmental retardation. Acta Neuropathol 1987,74(4),397-401","journal-title":"Acta Neuropathol"},{"key":"ref=152","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.37572","volume":"170","author":"Brasseur B.","year":"2016","unstructured":"Brasseur B.; Martin C. M.; Cayci Z.; Burmeister L.; Schimmenti L. A.; Bosma arhinia microphthalmia syndrome: Clinical report and review of the literature. Am J Med Genet Part A 2016,170(5)","journal-title":"Am J Med Genet Part A"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"189-193","DOI":"10.1002\/ajmg.a.31039","volume":"140 A","author":"Graham J. M.","year":"2006","unstructured":"Graham J. M.; Lee J.; Bosma arhinia microphthalmia syndrome. Am J Med Genet 2006,140 A(2),189-193","journal-title":"Am J Med Genet"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ajhg.2008.12.017","volume":"84","author":"Lahiry P.","year":"2009","unstructured":"Lahiry P.; Wang J.; Robinson J.F.; Turowec J.P.; Litchfield D.W.; Lanktree M.B.; Gloor G.B.; Puffenberger E.G.; Strauss K.A.; Martens M.B.; Ramsay D.A.; Rupar C.A.; Siu V.; Hegele R.A.; A multiplex human syndrome implicates a key role for intestinal cell kinase in development of central nervous, skeletal, and endocrine systems. Am J Hum Genet 2009,84(2),134-147","journal-title":"Am J Hum Genet"},{"key":"ref=155","first-page":"39","volume":"9","author":"Moerman P.","year":"1998","unstructured":"Moerman P.; Fryns J.P.; Oral-facial-digital syndrome type IV (Mohr-Majewski syndrome): a fetopathological study. Genet Couns 1998,9(1),39-43","journal-title":"Genet Couns"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ajhg.2012.06.017","volume":"91","author":"Thomas S.","year":"2012","unstructured":"Thomas S.; Legendre M.; Saunier S.; Bessi\u00e8res B.; Alby C.; Bonni\u00e8re M.; Toutain A.; Loeuillet L.; Szymanska K.; Jossic F.; Gaillard D.; Yacoubi M.T.; Mougou-Zerelli S.; David A.; Barthez M.A.; Ville Y.; Bole-Feysot C.; Nitschke P.; Lyonnet S.; Munnich A.; Johnson C.A.; Encha-Razavi F.; Cormier-Daire V.; Thauvin-Robinet C.; Vekemans M.; Atti\u00e9-Bitach T.; TCTN3 mutations cause Mohr-Majewski syndrome. Am J Hum Genet 2012,91(2),372-378","journal-title":"Am J Hum Genet"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00491508","volume":"116","author":"Spranger J.","year":"1974","unstructured":"Spranger J.; Grimm B.; Weller M.; Weissenbacher G.; Herrmann J.; Gilbert E.; Krepler R.; Short rib-polydactyly (SRP) syndromes, types Majewski and Saldino-Noonan. Z Kinderheilkd 1974,116(2),73-94","journal-title":"Z Kinderheilkd"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1038\/s41598-017-02947-y","volume":"7","author":"Sailani M.R.","year":"2017","unstructured":"Sailani M.R.; Jingga I.; MirMazlomi, S.H.; Bitarafan, F.; Bernstein, J.A.; Snyder, M.P.; Garshasbi, M. Isolated congenital anosmia and CNGA2 mutation. Sci Rep 2017,7(1),2667","journal-title":"Sci Rep"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cge.12491","volume":"88","author":"Karstensen H.G.","year":"2015","unstructured":"Karstensen H.G.; Mang Y.; Fark T.; Hummel T.; Tommerup N.; The first mutation in CNGA2 in two brothers with anosmia. Clin Genet 2015,88(3),293-296","journal-title":"Clin Genet"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/cge.12782","volume":"90","author":"Alkelai A.","year":"2016","unstructured":"Alkelai A.; Olender T.; Haffner-Krausz R.; Tsoory M.M.; Boyko V.; Tatarskyy P.; Gross-Isseroff R.; Milgrom R.; Shushan S.; Blau I.; Cohn E.; Beeri R.; Levy-Lahad E.; Pras E.; Lancet D.; A role for TENM1 mutations in congenital general anosmia. Clin Genet 2016,90(3),211-219","journal-title":"Clin Genet"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature09975","volume":"472","author":"Weiss J.","year":"2011","unstructured":"Weiss J.; Pyrski M.; Jacobi E.; Bufe B.; Willnecker V.; Schick B.; Zizzari P.; Gossage S.J.; Greer C.A.; Leinders-Zufall T.; Woods C.G.; Wood J.N.; Zufall F.; Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature 2011,472(7342),186-190","journal-title":"Nature"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/158835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T12:45:18Z","timestamp":1721652318000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/158835\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":161,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,8,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180105102447","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}